Skip to main content
SpringerLink
Log in

Wearable cardioverter defribrillator use after ICD explantation may be cost saving for preventing SCD

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. The research was partly funded by ZOLL.

Reference

  • Boriani G, et al. Cost-minimization analysis of a wearable cardioverter defibrillator in adult patients undergoing ICD explant procedures: Clinical and economic implications. Clinical Cardiology : 24 Aug 2021. Available from: URL: http://doi.org/10.1002/clc.23709

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wearable cardioverter defribrillator use after ICD explantation may be cost saving for preventing SCD. PharmacoEcon Outcomes News 886, 28 (2021). https://doi.org/10.1007/s40274-021-08006-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-08006-4

Search

Navigation